UCLA Division of Hematology-Oncology — Los Angeles, California

UCLA Division of Hematology-Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Division of Hematology-Oncology has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Non Small Cell Lung Cancer, Colorectal Cancer.

Sponsors: Cyclacel Pharmaceuticals, Inc., Fate Therapeutics.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Division of Hematology-Oncology?

UCLA Division of Hematology-Oncology has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Division of Hematology-Oncology conducted?

UCLA Division of Hematology-Oncology has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia, Non Small Cell Lung Cancer, Colorectal Cancer.

Is UCLA Division of Hematology-Oncology accredited by Crixeo Health?

UCLA Division of Hematology-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Division of Hematology-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.